公司概覽
業務類別 Medical Devices
業務概覽 Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
公司地址 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
電話號碼 +1 224 667-6100
傳真號碼 --
公司網頁 https://www.abbott.com
員工數量 115000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 美元 1.50M 20/02/2026
Mr. Daniel Gesua Sive Salvadori Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products 美元 879.27K 20/02/2026
Mr. Eric Shroff Senior Vice President, Rapid and Molecular Diagnostics -- 20/02/2026
Mr. Christopher J. Scoggins Executive Vice President, Diabetes Care -- 20/02/2026
Ms. Mary K. Moreland Executive Vice President, Human Resources -- 20/02/2026
Ms. Lisa D. Earnhardt Executive Vice President and Group President, Medical Devices 美元 879.27K 20/02/2026
Mr. Philip P. Boudreau Executive Vice President, Finance and Chief Financial Officer 美元 884.04K 20/02/2026
Mr. Louis H. Morrone Executive Vice President, Core Diagnostics -- 20/02/2026
Ms. Elizabeth C. Cushman Executive Vice President, General Counsel and Secretary -- 20/02/2026
Mr. John A. Mccoy, Jr Vice President, Finance, Controller and Principal Accounting Officer -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Dr. Robert J. Alpern,M.D. Independent Director 20/02/2026
Mr. John G. Stratton Independent Director 20/02/2026
Ms. Nancy Mckinstry Lead Independent Director 20/02/2026
Dr. Sally E. Blount, PhD Independent Director 20/02/2026
Mr. Michael F. Roman Independent Director 20/02/2026
Mr. Robert B. Ford Chairman of the Board and Chief Executive Officer 20/02/2026
Mr. Daniel J. Starks Independent Director 20/02/2026
General Darren W. McDew, U.S.A.F. (Ret.) Independent Director 20/02/2026
Ms. Patricia P. Gonzalez Independent Director 20/02/2026
Ms. Michelle A. Kumbier Independent Director 20/02/2026
Mr. Michael G. O’Grady Independent Director 20/02/2026
Ms. Claire Babineaux-Fontenot Independent Director 20/02/2026
Ms. Nita Ahuja, M.D. Director 20/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:44)
代號 名稱 佔比% 持有日期
DCORDimensional US Core Equity 1 ETF0.003%27/02/2026
QVMLInvesco S&P 500 QVM Multi-factor ETF0.003%27/02/2026
BDVLiShares Disciplined Vol Eq Act ETF0.003%13/02/2026
HLALWahed FTSE USA Shariah ETF0.003%27/02/2026
FTHIFirst Trust BuyWrite Income ETF0.003%26/02/2026
MFSVMFS Active Value ETF0.003%27/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.003%27/02/2026
EFIVState Street® SPDR® S&P 500® ESG ETF0.002%27/02/2026
ETWEV Tax-Managed Glb B-W Opps0.002%31/12/2025
OMFLInvesco Russell 1000® Dynamic Mltfct ETF0.002%27/02/2026
LCTUiShares US Carb Trnstn Rdnss Awr Act ETF0.002%28/02/2026
NBCRNeuberger Core Equity ETF0.002%28/02/2026
QDPLPacer Metaurus US Lg Cp Dvd Mltp 400 ETF0.002%27/02/2026
CUREDirexion Daily Healthcare Bull 3X ETF0.002%26/02/2026
BEEXBeeHive ETF0.002%27/02/2026
PCGGPolen Capital Global Growth ETF0.002%31/12/2025
DHLXDiamond Hill Large Cap Concentrated ETF0.002%27/02/2026
EPSWisdomTree U.S. LargeCap Fund0.002%27/02/2026
ETOEV Tax Adv Global Div Opps0.002%31/12/2025
ILCBiShares Morningstar U.S. Equity ETF0.002%28/02/2026
  1    2    3    4    5    6   7    8    9    10    11    12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.